Variant | Gene | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||
---|---|---|---|---|---|---|---|---|---|---|
|
A | 0.700 | CausalMutation | CLINVAR | c.1437G>A intron 9 substitution on acid α-glucosidase gene associated with classic infantile-onset Pompe disease phenotype. | 26160551 | 2015 |
|||
|
0.700 | GeneticVariation | GWASCAT | Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. | 21348951 | 2011 |
||||
|
0.700 | GeneticVariation | GWASCAT | Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. | 21348951 | 2011 |
||||
|
0.700 | GeneticVariation | GWASCAT | Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. | 21348951 | 2011 |
||||
|
0.700 | GeneticVariation | GWASCAT | Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. | 21348951 | 2011 |
||||
|
0.700 | GeneticVariation | GWASCAT | Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. | 21348951 | 2011 |
||||
|
0.700 | GeneticVariation | GWASCAT | Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. | 21348951 | 2011 |
||||
|
0.700 | GeneticVariation | GWASCAT | Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. | 21348951 | 2011 |
||||
|
0.700 | GeneticVariation | GWASCAT | Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. | 21348951 | 2011 |
||||
|
0.700 | GeneticVariation | GWASCAT | Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. | 21348951 | 2011 |
||||
|
0.700 | GeneticVariation | GWASCAT | Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. | 21348951 | 2011 |